iscripttm reverse transcription supermix 217 (TaKaRa)
TaKaRa is a verified supplier 
TaKaRa manufactures this product 
99
Structured Review
TaKaRa
iscripttm reverse transcription supermix 217
Iscripttm Reverse Transcription Supermix 217, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 14890 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/iscripttm+reverse+transcription+supermix/PrimeScript+RT+Reagent+Kit+with+gDNA+Eraser/pm41643872-121-28-34
Average 99 stars, based on 14890 article reviews
Iscripttm Reverse Transcription Supermix 217, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 14890 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/iscripttm+reverse+transcription+supermix/PrimeScript+RT+Reagent+Kit+with+gDNA+Eraser/pm41643872-121-28-34
Average 99 stars, based on 14890 article reviews
iscripttm reverse transcription supermix 217 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Isolation:Article Title: Endothelial JMJD1C drives pathological ocular neovascularization by activating SREBF2-dependent cholesterol biosynthesis. Article Snippet: Background: Pathological ocular neovascularization is closely linked to aberrant histone modifications, yet the underlying molecular mechanisms remain incompletely defined.. This study investigates the role of the histone demethylase JMJD1C and its encoding gene Jmjd1c in driving pathological angiogenesis and evaluates its therapeutic potential in ocular proliferative vascular diseases.. Methods: Jmjd1c expression was examined in mouse models of ocular neovascularization and in endothelial cells (ECs) using immunostaining, qRT-PCR, and Western blotting. Reverse Transcription:Article Title: Endothelial JMJD1C drives pathological ocular neovascularization by activating SREBF2-dependent cholesterol biosynthesis. Article Snippet: Background: Pathological ocular neovascularization is closely linked to aberrant histone modifications, yet the underlying molecular mechanisms remain incompletely defined.. This study investigates the role of the histone demethylase JMJD1C and its encoding gene Jmjd1c in driving pathological angiogenesis and evaluates its therapeutic potential in ocular proliferative vascular diseases.. Methods: Jmjd1c expression was examined in mouse models of ocular neovascularization and in endothelial cells (ECs) using immunostaining, qRT-PCR, and Western blotting. |